| |
Run-in period (2 weeks)
|
Intervention period (8 weeks)
|
|---|
|
Treatment
|
Run-in oil (n = 155)
|
Echium oil (study 1) (n = 59)
|
Linseed oil mixture (study 2) (n = 59)
|
Control groups
|
|---|
|
Fish oilb (study 1) (n = 19)
|
Olive oil (study 2) (n = 18)
|
|---|
| |
%
|
g/d
|
%
|
g/d
|
%
|
g/d
|
%
|
g/d
|
%
|
g/d
|
|---|
|
Oil dose
| |
17
| |
17
| |
17
| |
17
| |
17
|
|
FA groups and individual FA
| | | | | | | | | | |
|
∑SFA
|
44
|
7.5
|
11
|
1.8
|
9.0
|
1.4
|
12
|
2.1
|
14
|
2.1
|
|
∑MUFA (mainly 18:1n-9)
|
39
|
6.7
|
18
|
3.0
|
38
|
5.9
|
66
|
12
|
80
|
12
|
|
∑PUFA
|
16
|
2.8
|
70
|
12
|
53
|
8.1
|
22
|
3.3
|
6.0
|
0.9
|
|
18:2n-6, LA
|
16
|
2.8
|
17
|
2.9
|
22
|
3.3
|
5.7
|
0.9
|
5.5
|
0.8
|
|
18:3n-6, GLA
|
−
|
−
|
11
|
1.8
|
−
|
−
|
0.1
|
−
|
−
|
−
|
|
18:3n-3, ALA
|
0.2
|
−
|
30
|
5.0
|
31
|
4.9
|
0.6
|
0.1
|
0.5
|
0.1
|
|
18:4n-3, SDA
|
−
|
−
|
12
|
2.0
|
−
|
−
|
1.2
|
0.2
|
−
|
−
|
|
20:5n-3, EPA
|
−
|
−
|
−
|
−
|
−
|
−
|
11
|
1.9
|
−
|
−
|
|
22:5n-3, DPA
|
−
|
−
|
−
|
−
|
−
|
−
|
0.2
|
−
|
−
|
−
|
|
22:6n-3, DHA
|
−
|
−
|
−
|
−
|
−
|
−
|
1.4
|
0.2
|
−
|
−
|
|
n-6/n-3
|
80/1
|
0.7/1
|
0.7/1
|
0.4/1
|
11/1
|
-
aData are means of men and women. - indicates < 0.1 g/100 g or < 0.1 g/d. bFish oil (EPA:DHA, 9:1) blended with olive oil
